Cargando…

Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder

BACKGROUND: The prognostic significance of tumoral programmed death-ligand 2 (PD-L2) expression in urothelial bladder cancer (UBCs) is under-investigated , although it can potentially to become a regulatory agent of cancer immunity. In the search for supporting biomarkers, the neutrophil-to-lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendri, Ahmad Zulfan, Soerohardjo, Indrawarman, Heriyanto, Didik Setyo, Khalilullah, Said Alfin, Dany, Yurisal Akhmad, Danurdoro, Aria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685214/
https://www.ncbi.nlm.nih.gov/pubmed/37642053
http://dx.doi.org/10.31557/APJCP.2023.24.8.2673
_version_ 1785151580416245760
author Hendri, Ahmad Zulfan
Soerohardjo, Indrawarman
Heriyanto, Didik Setyo
Khalilullah, Said Alfin
Dany, Yurisal Akhmad
Danurdoro, Aria
author_facet Hendri, Ahmad Zulfan
Soerohardjo, Indrawarman
Heriyanto, Didik Setyo
Khalilullah, Said Alfin
Dany, Yurisal Akhmad
Danurdoro, Aria
author_sort Hendri, Ahmad Zulfan
collection PubMed
description BACKGROUND: The prognostic significance of tumoral programmed death-ligand 2 (PD-L2) expression in urothelial bladder cancer (UBCs) is under-investigated , although it can potentially to become a regulatory agent of cancer immunity. In the search for supporting biomarkers, the neutrophil-to-lymphocyte ratio (NLR) as a readily available surrogate marker of immune status has been associated with clinical outcomes and other prognostic factors in various types of cancer. Here we evaluate the prognostic ability of baseline NLR in addition to PD-L2 expression in bladder cancer. METHODS: We used a retrospective cohort of UBCs patients from the authors’ institutions. We classified patients according to their PD-L2 and NLR levels. We associated the prognostic outcome of each group with disease-free survival (DFS) and overall survival (OS). RESULTS: Thirty patients had a tumor with positive PD-L2 expression. We found no significant correlation between PD-L2 expression and NLR. PD-L2 status failed to provide a significant prognostic impact (disease-free survival [DFS] and overall survival [OS] rate at 5 years, 42.85% in PD-L2-high versus 65.75% in PD-L2-low patients; p = 0.057, 42.85% in PD-L2-high patients versus 62.5% in PD-L2-low patients; p = 0.112, respectively). NLR status also failed to exhibit a significant prognostic impact (DFS and OS rate at 5 years, 44.44% in PD-L2-high versus 66.66% in PD-L2-low patients; p = 0.232, 55.55% in PD-L2-high versus 71.43% in PD-L2-low patients; P = 0.894, respectively). When PD-L2 status and NLR status were combined, the NLR-low and PD-L2-low were significant factors to predict a favorable disease-free survival (hazard ratio, 4.525 [95% confidence interval, 1.020 to 20.080]; P = 0.047. However, the multivariate analysis failed to show it as an independent factor. CONCLUSION: These findings suggest that the prognostic impact of PD-L2 expression could be affected by the NLR status.
format Online
Article
Text
id pubmed-10685214
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-106852142023-11-30 Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder Hendri, Ahmad Zulfan Soerohardjo, Indrawarman Heriyanto, Didik Setyo Khalilullah, Said Alfin Dany, Yurisal Akhmad Danurdoro, Aria Asian Pac J Cancer Prev Research Article BACKGROUND: The prognostic significance of tumoral programmed death-ligand 2 (PD-L2) expression in urothelial bladder cancer (UBCs) is under-investigated , although it can potentially to become a regulatory agent of cancer immunity. In the search for supporting biomarkers, the neutrophil-to-lymphocyte ratio (NLR) as a readily available surrogate marker of immune status has been associated with clinical outcomes and other prognostic factors in various types of cancer. Here we evaluate the prognostic ability of baseline NLR in addition to PD-L2 expression in bladder cancer. METHODS: We used a retrospective cohort of UBCs patients from the authors’ institutions. We classified patients according to their PD-L2 and NLR levels. We associated the prognostic outcome of each group with disease-free survival (DFS) and overall survival (OS). RESULTS: Thirty patients had a tumor with positive PD-L2 expression. We found no significant correlation between PD-L2 expression and NLR. PD-L2 status failed to provide a significant prognostic impact (disease-free survival [DFS] and overall survival [OS] rate at 5 years, 42.85% in PD-L2-high versus 65.75% in PD-L2-low patients; p = 0.057, 42.85% in PD-L2-high patients versus 62.5% in PD-L2-low patients; p = 0.112, respectively). NLR status also failed to exhibit a significant prognostic impact (DFS and OS rate at 5 years, 44.44% in PD-L2-high versus 66.66% in PD-L2-low patients; p = 0.232, 55.55% in PD-L2-high versus 71.43% in PD-L2-low patients; P = 0.894, respectively). When PD-L2 status and NLR status were combined, the NLR-low and PD-L2-low were significant factors to predict a favorable disease-free survival (hazard ratio, 4.525 [95% confidence interval, 1.020 to 20.080]; P = 0.047. However, the multivariate analysis failed to show it as an independent factor. CONCLUSION: These findings suggest that the prognostic impact of PD-L2 expression could be affected by the NLR status. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10685214/ /pubmed/37642053 http://dx.doi.org/10.31557/APJCP.2023.24.8.2673 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Article
Hendri, Ahmad Zulfan
Soerohardjo, Indrawarman
Heriyanto, Didik Setyo
Khalilullah, Said Alfin
Dany, Yurisal Akhmad
Danurdoro, Aria
Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
title Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
title_full Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
title_fullStr Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
title_full_unstemmed Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
title_short Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
title_sort prognostic significance of pd-l2 expression in association with neutrophil-to-lymphocyte ratio in urothelial carcinoma of the bladder
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685214/
https://www.ncbi.nlm.nih.gov/pubmed/37642053
http://dx.doi.org/10.31557/APJCP.2023.24.8.2673
work_keys_str_mv AT hendriahmadzulfan prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder
AT soerohardjoindrawarman prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder
AT heriyantodidiksetyo prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder
AT khalilullahsaidalfin prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder
AT danyyurisalakhmad prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder
AT danurdoroaria prognosticsignificanceofpdl2expressioninassociationwithneutrophiltolymphocyteratioinurothelialcarcinomaofthebladder